Drug intelligence / Profile preview

MD-MUSCLE

Development stage: Phase 1
Lead developer: Guna
Administration: Periarticular, Intraarticular, Intramuscular, Intradermal

Overview

MD-MUSCLE is a collagen-based medical device intended to enhance muscle relaxation and functioning. It supports muscle tissue in bad posture disorders, improves joint mobility, and soothes local pain, pain at rest, or pain caused by movement and bad posture. The product contains collagen of porcine origin, which is chosen for its similarity to human collagen and low immunogenicity, making it safer than bovine collagen. MD-MUSCLE can be administered through periarticular, intra-articular, intramuscular, and intradermal injections.

Brand names: MD-MUSCLEGUNA MD-MUSCLE
Other names: MD Muscle GUNA collagen

Beyond the preview

Go deeper on MD-MUSCLE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MD-MUSCLE.

Explore the full profile